No association between Agent Orange exposure and monoclonal gammopathies.

03:10 EDT 24th May 2015 | BioPortfolio

Summary of "No association between Agent Orange exposure and monoclonal gammopathies."

No Summary Available


Department of Pathology, University of Tennessee Health Science Center, Memphis, TN, USA.

Journal Details

This article was published in the following journal.

Name: Annals of hematology
ISSN: 1432-0584


PubMed Articles [9156 Associated PubMed Articles listed on BioPortfolio]

Incidence of gammopathies in long-term plasmapheresis donors at Canadian Blood Services.

To investigate the long-term consequences of repeated plasmapheresis on donor health, their donation histories and demographic data were reviewed to determine the frequency of development of monoclona...

Paraproteinemic Neuropathies.

Monoclonal gammopathies are common in the general population and occur in 10% of patients with peripheral neuropathy. It is important for the clinician to be able to determine whether an association e...

Exposure to TCDD from base perimeter application of Agent Orange in Vietnam.

Using recognized methods routinely employed by pesticide regulatory agencies, the exposures of military personnel that were mixer/loader/applicators (M/L/A) of Agent Orange (AO) for perimeter foliage ...

Retention of single crystals of two Co(ii) complexes during chemical reactions and rearrangement.

Monomeric [Co(II)(hep-H)(H2O)4]SO4 []SO4 and [Co(II)(hep-H)2(H2O)2](NO3)2 [](NO3)2 have been developed from 2-(2-hydroxyethyl)pyridine (hep-H) and CoSO4·7H2O/Co(NO3)2·6H2O, respectively, at 298 K. O...

Monoclonal gammopathies of undetermined significance do not systematically require a specialized consultation.

Monoclonal gammopathy of undetermined significance (MGUS) is a frequent entity in the general population. The incidence rate of fortuitous discovery of a monoclonal component in asymptomatic patients ...

Clinical Trials [2623 Associated Clinical Trials listed on BioPortfolio]

Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.

Compare the effect of a single dose of fexofenadine HCl 180 mg plus orange juice versus placebo plus orange juice on the change from baseline (pre-dose) in histamine skin flares.

The Effects of Processed Whole Orange on Subjective Ratings of Satiety

The study is a human dietary test meal study that is a randomized, controlled, double blind, cross over design with 3 intervention arms that will investigate the subjective ratings of sati...

The Glycemic Effect of Taking a Supplementation of Orange Juice With Fibers

The aim of this study is to investigate the glycemic effect of supplementation Fibers in orange juice. This will be a double-blind parallel controlled study. Each subject will serve as hi...

Human Urinary Biomarker for Orange Juice Consumption

Human urinary metabolic profiling showed to be very successful to elucidate biomarkers linked to geographic origin and specific food consumption patterns (Holmes and Loo et al.: Human meta...

Impact of Consumption of Orange-fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age

The primary purpose of this study is to determine whether daily consumption of orange-fleshed sweet potatoes increases the vitamin A status of Bangladeshi women of reproductive age. Secon...

Medical and Biotech [MESH] Definitions

A plant species of the genus CITRUS, family RUTACEAE that provides the familiar orange fruit which is also a source of orange oil.

Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.

A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

The prevention of infection or disease following exposure to a pathogen. This is most frequently addressed by administering a vaccine or anti-viral medication following exposure to a virus.

Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).

Search BioPortfolio: